University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
NCT Number: NCT02942121
The purpose of this study is to learn whether it is feasible to use the LifeScience Technologies application (LST app) in patients undergoing radical cystectomy with the eventual goal to reduce complications and readmissions to the hospital after surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kansas City, Kansas, 66160, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Application for mobile devices. The app enables users to review educational videos about a surgery and recovery from a surgery from home. It also enables the user to track different metrics specific to the user's health.
Other names: LST app
Time frame: 90 Days
The LST app logs user activity. The study team will track user compliance with completing forms and questions within the application.
Time frame: Baseline
Test the PG-SGA using the LST app to see if it is feasible in practice at identifying patients at increased risk of malnutrition.
Time frame: Baseline
Test the EFS using the LST app to see if it is feasible in practice at identifying frail patients.
Time frame: Change from Baseline to Day 90
Measure of how well the patient understood the various tests and procedures that were discussed with them before and after surgery.
Time frame: Day 90
Count of the number of readmissions to the hospital.
University of Kansas Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03924856
Bladder Cancer, Female Urogenital Diseases
La Jolla, California, United States
View Trial DetailsNCT04081246
Bladder Cancer, Bladder Neoplasm
Hong Kong
View Trial DetailsNCT05512377
Biliary Tract Cancer, Biliary Tract Diseases
Mobile, Alabama, United States
View Trial DetailsNCT06955910
Behavior, Behavioral Symptoms
Padova, Italy/Padova, Italy
View Trial Details